Interferon'splays role in innate immune responses through upregulation of costimulatory molecules and induction of proinflammatory cytokines.interferons including interferon alpha (IFNA). The present study characterized IFNA cDNA and predicted protein.The interferon's play a great role in protection from infections, which have been called by microorganisms, and also have powerful antiproliferation and immunomodulation activity.The purposes of study:cloning andexpression of horse leukocyte interferonand purification the product protein.
Introduction
In interferon (IFNs) were discovered in 1957 as a biological agent intervention in viral replication. They are mixtures of the secrets of proteins occurring in vertebrates and can be classified as cytokines. Interferon's are multifunctional components of defense against viral and parasitic infections and certain tumors. They affect the immune system function in various forms, interferon's perform various activities, primarily synthesize many proteins.Interferon's are useful in the case of many human diseases: in leukemia, Kaposi 
Results and discussion
Geneamplification equine leukocyte α-interferon with helps PCR used total DNA isolated from horse blood. At database GeneBank nucleotide sequences (codes M14540, M14541, M14542, M14543) primers were designed: F1 (5-GGC CATATG TGT GAC CTG CCT CAC ACC CAT AGC CTG GGC-3 Select a site for restriction endonuclease Nde1) and R1 (5-gcg GAATTC GAT AAGCTT ACT CTG CTG CAA GTT TGT GGA TGA AGA GAA -3 allocated sites for restriction enzymes Eco R1 and HindIII) product size amplification equine interferon gene is (483) bp that is fully consistent with the expected (figure 1).
Figure 1. Gene equine leukocyte α-interferon
The amplification product is embedded into a plasmid PUC18 of restriction sites for Nde I and Eco RI,(neb.com/restriction_enzymes)then spent his sequencing, which showed that the nucleotide sequence of the amplified fragment is equal to a full sequence of the gene equine leukocyte α-interferon in the database. plasmid gene equine interferon produced on the selective medium EMB. The presence of inserts equine interferon gene in the plasmid pUC18 tested PCR analysis using primers F1 and R1, complementary to the 5'-and Z'-terminal sequences of equine interferon gene (Fig. 1) , and restriction analysis (Fig. 3) . The amplification product is embedded into a plasmid PUC18 the sites for the restriction Nde I and EcoR I. then spent his sequencing, which showed that the nucleotide sequence of the amplified fragment is equal to a full sequence of the gene equine leukocyte α-interferon in the database.In the next stage of the gene equine leukocyte α-interferontransferred into an expression vector pET24b (+) for restriction endonuclease sites Nde I-Eco RI. The resulting recombinant plasmids, named respectively M14541, (Figure 4 These results indicate that after the induction of IPTG in bacterial cells (Frank C.), containing the recombinant plasmid with the gene of equine leukocyteα-interferon, there is accumulation of the protein corresponding to the molecular weight of horse α-interferon (about 5.81 kDa ).
On these results we can conclude:  Using the designed specific primers amplification gene and the equine leukocyte α-interferon.  Amplification product of the sequenced and cloned into the expression vector.  Protein produced by size-fits to equine leukocyte α-interferon(about 5.81 kDa ).
